257 related articles for article (PubMed ID: 37065173)
1. P2-type purinergic signaling in the regulation of pancreatic β-cell functional plasticity as a promising novel therapeutic approach for the treatment of type 2 diabetes?
Mesto N; Movassat J; Tourrel-Cuzin C
Front Endocrinol (Lausanne); 2022; 13():1099152. PubMed ID: 37065173
[TBL] [Abstract][Full Text] [Related]
2. Involvement of P2X receptors in the regulation of insulin secretion, proliferation and survival in mouse pancreatic β-cells.
Ohtani M; Ohura K; Oka T
Cell Physiol Biochem; 2011; 28(2):355-66. PubMed ID: 21865744
[TBL] [Abstract][Full Text] [Related]
3. P2 purinergic signalling in the pancreatic beta-cell: control of insulin secretion and pharmacology.
Petit P; Lajoix AD; Gross R
Eur J Pharm Sci; 2009 May; 37(2):67-75. PubMed ID: 19429412
[TBL] [Abstract][Full Text] [Related]
4. Extracellular adenosine 5'-triphosphate modulates insulin secretion via functionally active purinergic receptors of X and Y subtype.
Santini E; Cuccato S; Madec S; Chimenti D; Ferrannini E; Solini A
Endocrinology; 2009 Jun; 150(6):2596-602. PubMed ID: 19196799
[TBL] [Abstract][Full Text] [Related]
5. Electrophysiological and immunocytochemical evidence for P2X purinergic receptors in pancreatic beta cells.
Silva AM; Rodrigues RJ; Tomé AR; Cunha RA; Misler S; Rosário LM; Santos RM
Pancreas; 2008 Apr; 36(3):279-83. PubMed ID: 18362842
[TBL] [Abstract][Full Text] [Related]
6. Evidence for two different types of P2 receptors stimulating insulin secretion from pancreatic B cell.
Petit P; Hillaire-Buys D; Manteghetti M; Debrus S; Chapal J; Loubatières-Mariani MM
Br J Pharmacol; 1998 Nov; 125(6):1368-74. PubMed ID: 9863669
[TBL] [Abstract][Full Text] [Related]
7. Changes in expression of P2 receptors in rat and mouse pancreas during development and ageing.
Coutinho-Silva R; Parsons M; Robson T; Burnstock G
Cell Tissue Res; 2001 Dec; 306(3):373-83. PubMed ID: 11735037
[TBL] [Abstract][Full Text] [Related]
8. Modulation of P2 receptors on pancreatic β-cells by agonists and antagonists: a molecular target for type 2 diabetes treatment.
Pacheco PA; Ferreira LG; Alves LA; Faria RX
Curr Diabetes Rev; 2013 May; 9(3):228-36. PubMed ID: 23506378
[TBL] [Abstract][Full Text] [Related]
9. Purinergic signaling in the pancreas and the therapeutic potential of ecto-nucleotidases in diabetes.
Cieślak M; Roszek K
Acta Biochim Pol; 2014; 61(4):655-62. PubMed ID: 25522227
[TBL] [Abstract][Full Text] [Related]
10. Chronic fructose renders pancreatic β-cells hyper-responsive to glucose-stimulated insulin secretion through extracellular ATP signaling.
Bartley C; Brun T; Oberhauser L; Grimaldi M; Molica F; Kwak BR; Bosco D; Chanson M; Maechler P
Am J Physiol Endocrinol Metab; 2019 Jul; 317(1):E25-E41. PubMed ID: 30912960
[TBL] [Abstract][Full Text] [Related]
11. ADP mediates inhibition of insulin secretion by activation of P2Y13 receptors in mice.
Amisten S; Meidute-Abaraviciene S; Tan C; Olde B; Lundquist I; Salehi A; Erlinge D
Diabetologia; 2010 Sep; 53(9):1927-34. PubMed ID: 20526761
[TBL] [Abstract][Full Text] [Related]
12. Purinergic receptors in the endocrine and exocrine pancreas.
Novak I
Purinergic Signal; 2008 Sep; 4(3):237-53. PubMed ID: 18368520
[TBL] [Abstract][Full Text] [Related]
13. Purinergic signaling in diabetes and metabolism.
Jain S; Jacobson KA
Biochem Pharmacol; 2021 May; 187():114393. PubMed ID: 33359363
[TBL] [Abstract][Full Text] [Related]
14. ATP-gated P2X3 receptors constitute a positive autocrine signal for insulin release in the human pancreatic beta cell.
Jacques-Silva MC; Correa-Medina M; Cabrera O; Rodriguez-Diaz R; Makeeva N; Fachado A; Diez J; Berman DM; Kenyon NS; Ricordi C; Pileggi A; Molano RD; Berggren PO; Caicedo A
Proc Natl Acad Sci U S A; 2010 Apr; 107(14):6465-70. PubMed ID: 20308565
[TBL] [Abstract][Full Text] [Related]
15. Involvement of P2Y signaling in the restoration of glucose-induced insulin exocytosis in pancreatic β cells exposed to glucotoxicity.
Mesto N; Bailbe D; Eskandar M; Pommier G; Gil S; Tolu S; Movassat J; Tourrel-Cuzin C
J Cell Physiol; 2022 Jan; 237(1):881-896. PubMed ID: 34435368
[TBL] [Abstract][Full Text] [Related]
16. Intracellular and extracellular adenosine triphosphate in regulation of insulin secretion from pancreatic β cells (β).
Wang C; Geng B; Cui Q; Guan Y; Yang J
J Diabetes; 2014 Mar; 6(2):113-9. PubMed ID: 24134160
[TBL] [Abstract][Full Text] [Related]
17. Cross talk between P2 purinergic receptors modulates extracellular ATP-mediated interleukin-10 production in rat microglial cells.
Seo DR; Kim SY; Kim KY; Lee HG; Moon JH; Lee JS; Lee SH; Kim SU; Lee YB
Exp Mol Med; 2008 Feb; 40(1):19-26. PubMed ID: 18305394
[TBL] [Abstract][Full Text] [Related]
18. Molecular and Pharmacological Evidence for the Expression of Multiple Functional P2 Purinergic Receptors in Human Adipocytes.
Rossato M; Favaretto F; Granzotto M; Crescenzi M; Boscaro A; Di Vincenzo A; Capone F; Dalla Nora E; Zabeo E; Vettor R
Molecules; 2022 Mar; 27(6):. PubMed ID: 35335277
[TBL] [Abstract][Full Text] [Related]
19. P2 receptor signaling in neurons and glial cells of the central nervous system.
Köles L; Leichsenring A; Rubini P; Illes P
Adv Pharmacol; 2011; 61():441-93. PubMed ID: 21586367
[TBL] [Abstract][Full Text] [Related]
20. That was then, this is now: the development of our knowledge and understanding of P2 receptor subtypes.
Kennedy C
Purinergic Signal; 2021 Mar; 17(1):9-23. PubMed ID: 33527235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
